Loblaw Companies Limited · TSX:L
Loblaw Companies — Q2 2026 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Jun 20, 2026
Slide 1: Supplementary Slides Q2 2026
SUPPLEMENTARY SLIDES Q2 2026 For the periods ended June 20, 2026 and June 14, 2025 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Total Company
KEY FINANCIAL METRICS – Total Company(1) Q2 2026 (millions of Canadian dollars unless otherwise noted) Q2 2026 Q2 2025 % Change(2) Revenue (including Retail and PC Financial) $15,270 $14,672 ↑ +4.1% Adjusted EBITDA $1,924 $1,831 ↑ +5.1% Adjusted EBITDA Margin 12.6% 12.5% ↑ +10 bps Adjusted Net Earni
Slide 4: Key Financial Metrics – Retail
KEY FINANCIAL METRICS – Retail(1) Q2 2026 (millions of Canadian dollars unless otherwise noted) Q2 2026 Q2 2025 % Change(2) Retail Revenue $15,046 $14,457 ↑ +4.1% Retail Revenue - Food $10,617 $10,281 Retail Revenue - Drug $4,429 $4,176 Pharmacy and Healthcare Services $2,450 $2,255 Front Store $1,9
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q2 2026 Food Retail (Loblaw) % Change(1) Food Retail Same-Store Sales Growth ↑ +1.6% Basket Size(2) ↑ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +4.6%